119 related articles for article (PubMed ID: 29929138)
1. Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.
Tabib A; Hindi I; Karbian N; Zelig O; Falach B; Mevorach D
Thromb Res; 2018 Aug; 168():67-77. PubMed ID: 29929138
[TBL] [Abstract][Full Text] [Related]
2. The dysfunction of platelets in paroxysmal nocturnal hemoglobinuria.
Fu R; Meng Y; Wang Y; Liu H; Liu Y; Li L; Ding S; Wang G; Song J; Shao Z
Thromb Res; 2016 Dec; 148():50-55. PubMed ID: 27780113
[TBL] [Abstract][Full Text] [Related]
3. Demyelination, strokes, and eculizumab: Lessons from the congenital CD59 gene mutations.
Tabib A; Karbian N; Mevorach D
Mol Immunol; 2017 Sep; 89():69-72. PubMed ID: 28622911
[TBL] [Abstract][Full Text] [Related]
4. Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities.
Mevorach D
Mol Immunol; 2015 Sep; 67(1):51-5. PubMed ID: 25818314
[TBL] [Abstract][Full Text] [Related]
5. CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy.
Nevo Y; Ben-Zeev B; Tabib A; Straussberg R; Anikster Y; Shorer Z; Fattal-Valevski A; Ta-Shma A; Aharoni S; Rabie M; Zenvirt S; Goldshmidt H; Fellig Y; Shaag A; Mevorach D; Elpeleg O
Blood; 2013 Jan; 121(1):129-35. PubMed ID: 23149847
[TBL] [Abstract][Full Text] [Related]
6. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria.
Holt DS; Botto M; Bygrave AE; Hanna SM; Walport MJ; Morgan BP
Blood; 2001 Jul; 98(2):442-9. PubMed ID: 11435315
[TBL] [Abstract][Full Text] [Related]
7. Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency.
Ben-Zeev B; Tabib A; Nissenkorn A; Garti BZ; Gomori JM; Nass D; Goldshmidt H; Fellig Y; Anikster Y; Nevo Y; Elpeleg O; Mevorach D
Eur J Paediatr Neurol; 2015 Nov; 19(6):688-93. PubMed ID: 26233519
[TBL] [Abstract][Full Text] [Related]
8. Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation.
Mevorach D; Reiner I; Grau A; Ilan U; Berkun Y; Ta-Shma A; Elpeleg O; Shorer Z; Edvardson S; Tabib A
Ann Neurol; 2016 Nov; 80(5):708-717. PubMed ID: 27568864
[TBL] [Abstract][Full Text] [Related]
9. [Study on C5b-9 deposited on the membrane of platelets and its dysfunction in patients with paroxysmal nocturnal hemoglobinuria].
Meng Y; Fu R; Liu H; Wang Y; Li L; Liu C; Zhang T; Ding S; Li L; Ruan E; Qu W; Wang H; Wang X; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Shao Z
Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):516-9. PubMed ID: 26134020
[TBL] [Abstract][Full Text] [Related]
10. CD59 deficiency presenting as polyneuropathy and Moyamoya syndrome with endothelial abnormalities of small brain vessels.
Klemann C; Kirschner J; Ammann S; Urbach H; Moske-Eick O; Zieger B; Lorenz MR; Schwarz K; Doostkam S; Ehl S; Korinthenberg R
Eur J Paediatr Neurol; 2018 Sep; 22(5):870-877. PubMed ID: 29843966
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Demyelinating Episodes as Sole Manifestation of Inherited CD59 Deficiency.
Solmaz I; Aytekin ES; Çağdaş D; Tan C; Tezcan I; Gocmen R; Haliloglu G; Anlar B
Neuropediatrics; 2020 Jun; 51(3):206-210. PubMed ID: 31752029
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis for a link between complement and the vascular complications of diabetes.
Acosta J; Hettinga J; Flückiger R; Krumrei N; Goldfine A; Angarita L; Halperin J
Proc Natl Acad Sci U S A; 2000 May; 97(10):5450-5. PubMed ID: 10805801
[TBL] [Abstract][Full Text] [Related]
13. Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.
Amer J; Zelig O; Fibach E
Exp Hematol; 2008 Apr; 36(4):369-77. PubMed ID: 18261835
[TBL] [Abstract][Full Text] [Related]
14. Rare event counting of CD59- red cells in human blood: A 47-month experience using PNH consensus guidelines for WBC and RBC testing in a reference lab.
Liew M; Farley M; Andreasen J; Parker CJ; Wittwer CT
Cytometry B Clin Cytom; 2015; 88(4):261-9. PubMed ID: 25605539
[TBL] [Abstract][Full Text] [Related]
15. Balancing role of nitric oxide in complement-mediated activation of platelets from mCd59a and mCd59b double-knockout mice.
Qin X; Hu W; Song W; Blair P; Wu G; Hu X; Song Y; Bauer S; Feelisch M; Leopold JA; Loscalzo J; Halperin JA
Am J Hematol; 2009 Apr; 84(4):221-7. PubMed ID: 19229985
[TBL] [Abstract][Full Text] [Related]
16. Detection of a soluble form of the complement membrane attack complex inhibitor CD59 in plasma after acute myocardial infarction.
Väkevä A; Lehto T; Takala A; Meri S
Scand J Immunol; 2000 Oct; 52(4):411-4. PubMed ID: 11013013
[TBL] [Abstract][Full Text] [Related]
17. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
Yuan FF; Bryant JA; Fletcher A
Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
[TBL] [Abstract][Full Text] [Related]
18. [Protection of PNH red blood cells from lysis by transferring GPI-anchored protein vesicles of normal human RBCs in vitro].
Yang Y; Xu C; Pan H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Aug; 21(4):278-81. PubMed ID: 12567450
[TBL] [Abstract][Full Text] [Related]
19. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.
Väkevä A; Laurila P; Meri S
Lab Invest; 1992 Nov; 67(5):608-16. PubMed ID: 1279272
[TBL] [Abstract][Full Text] [Related]
20. Shear stress-mediated changes in the expression of complement regulatory protein CD59 on human endothelial progenitor cells by ECM-integrinα
Cui X; Zhang X; Bu H; Liu N; Li H; Guan X; Yan H; Wang Y; Zhang H; Ding Y; Cheng M
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):416-421. PubMed ID: 28943429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
